Prices delayed by at least 15 minutes | Print
Poolbeg Pharma PLC (POLB)
ORD 0.02POpen
9.85p
Previous close
9.85p
Trade high
10.1p
Volume
401,943
Year high
12.10p
Year low
6.38p
Dividend yield
-
Market capitalisation
£49.75 mn
P/E ratio
-
ISIN
GB00BKPG7Z60
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 17/04/2024 | 04:25:53 | 10.1 | 30,000 | 3,030.00 |
| 17/04/2024 | 04:22:42 | 9.7 | 202 | 19.59 |
| 17/04/2024 | 04:01:42 | 10.06 | 7,500 | 754.50 |
| 17/04/2024 | 04:00:45 | 10.06 | 5,000 | 503.00 |
| 17/04/2024 | 04:00:11 | 10.06 | 15,000 | 1,509.00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.